Ads
related to: asln stock
Search results
Is ASLAN Pharmaceuticals (ASLN) Stock Outpacing Its Medical Peers This Year?
Zacks via Yahoo Finance· 1 year agoInvestors interested in Medical stocks should always be looking to find the best-performing...
Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year?
Zacks via Yahoo Finance· 2 months agoInvestors interested in Medical stocks should always be looking to find the best-performing...
Bears are Losing Control Over ASLAN Pharmaceuticals Ltd. (ASLN), Here's Why It's a 'Buy' Now
Zacks via Yahoo Finance· 1 year agoASLAN Pharmaceuticals Ltd. (ASLN) witnesses a hammer chart pattern, indicating support found by the...
ASLAN (ASLN) Down 25% on Mixed Results From Skin Disease Study
Zacks via Yahoo Finance· 11 months agoASLAN (ASLN) reports mixed results from a mid-stage study of eblasakimab in adult patients with...
ASLAN Pharmaceuticals Limited's (NASDAQ:ASLN) recent 25% pullback adds to one-year year losses,...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Given the large stake in the stock by institutions, ASLAN Pharmaceuticals' stock price...
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
Zacks via Yahoo Finance· 3 months agoASLAN (ASLN) rises on upbeat initial data from a phase II study of eblasakimab in patients with...
Is Apexigen, Inc. (APGN) Stock Outpacing Its Medical Peers This Year?
Zacks via Yahoo Finance· 1 year agoThe Medical group has plenty of great stocks, but investors should always be looking for companies...
Reasons to Add Acadia (ACAD) Stock to Your Portfolio Now
Zacks via Yahoo Finance· 8 months agoSan Diego, CA-based Acadia Pharmaceuticals Inc. ACAD is a commercial biopharmaceutical company...
What's Going On With ASLAN Pharmaceuticals Stock Today?
Benzinga via Yahoo Finance· 11 months agoASLAN Pharmaceuticals Ltd (NASDAQ: ASLN) released topline data from its TREK-AD Phase 2b...
Apellis' (APLS) Q3 Earnings Miss Estimates, Revenues Top Mark
Zacks via Yahoo Finance· 2 years agoApellis Pharmaceuticals, Inc. APLS reported a loss per share of $1.75 for third-quarter 2022, wider...
